This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2021 Apr;9(4):333-335.

doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29.

SARS-CoV-2 evolution and vaccines: cause for concern?

Thomas C Williams¹, Wendy A Burgers²

Affiliations

Affiliations

¹ Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. Electronic address: Thomas.Christie.Williams@ed.ac.uk.
² Division of Medical Virology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

PMID: 33524316
PMCID: PMC8009632
DOI: 10.1016/S2213-2600(21)00075-8

SARS-CoV-2 evolution and vaccines: cause for concern?

Thomas C Williams et al. Lancet Respir Med. 2021 Apr.

. 2021 Apr;9(4):333-335.

doi: 10.1016/S2213-2600(21)00075-8. Epub 2021 Jan 29.

Authors

Thomas C Williams¹, Wendy A Burgers²

Affiliations

¹ Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK. Electronic address: Thomas.Christie.Williams@ed.ac.uk.
² Division of Medical Virology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

PMID: 33524316
PMCID: PMC8009632
DOI: 10.1016/S2213-2600(21)00075-8

No abstract available

PubMed Disclaimer

Figures

None

See this image and copyright information in PMC

Similar articles

Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
Tcheou J, Raskin A, Singh G, Kawabata H, Bielak D, Sun W, González-Domínguez I, Sather DN, García-Sastre A, Palese P, Krammer F, Carreño JM. Tcheou J, et al. Front Immunol. 2021 Nov 18;12:791764. doi: 10.3389/fimmu.2021.791764. eCollection 2021. Front Immunol. 2021. PMID: 34868082 Free PMC article.
Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
Pascolo S. Pascolo S. Viruses. 2021 Feb 9;13(2):270. doi: 10.3390/v13020270. Viruses. 2021. PMID: 33572452 Free PMC article. Review.
CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization.
Haun BK, Lai CY, Williams CA, Wong TAS, Lieberman MM, Pessaint L, Andersen H, Lehrer AT. Haun BK, et al. Front Immunol. 2020 Oct 30;11:599587. doi: 10.3389/fimmu.2020.599587. eCollection 2020. Front Immunol. 2020. PMID: 33193454 Free PMC article.
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R, Gan ES, Chen S, Leong YS, Tan HC, Zhang SL, Yau C, Low JGH, Kalimuddin S, Matsuda D, Allen EC, Hartman P, Park KJ, Alayyoubi M, Bhaskaran H, Dukanovic A, Bao Y, Clemente B, Vega J, Roberts S, Gonzalez JA, Sablad M, Yelin R, Taylor W, Tachikawa K, Parker S, Karmali P, Davis J, Sullivan BM, Sullivan SM, Hughes SG, Chivukula P, Ooi EE. de Alwis R, et al. Mol Ther. 2021 Jun 2;29(6):1970-1983. doi: 10.1016/j.ymthe.2021.04.001. Epub 2021 Apr 5. Mol Ther. 2021. PMID: 33823303 Free PMC article.
The challenge of emerging SARS-CoV-2 mutants to vaccine development.
Li R, Liu J, Zhang H. Li R, et al. J Genet Genomics. 2021 Feb 20;48(2):102-106. doi: 10.1016/j.jgg.2021.03.001. Epub 2021 Apr 20. J Genet Genomics. 2021. PMID: 33994322 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Precision therapeutic targets for COVID-19.
Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y. Krumm ZA, et al. Virol J. 2021 Mar 29;18(1):66. doi: 10.1186/s12985-021-01526-y. Virol J. 2021. PMID: 33781287 Free PMC article. Review.
SARS-CoV-2 mutational variants may represent a new challenge to society, but not to the virucidal armamentarium.
Ijaz MK, Nims RW, McKinney J. Ijaz MK, et al. J Hosp Infect. 2021 Jun;112:121-123. doi: 10.1016/j.jhin.2021.03.013. Epub 2021 Mar 22. J Hosp Infect. 2021. PMID: 33766545 Free PMC article. No abstract available.
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients.
Garanina E, Hamza S, Stott-Marshall RJ, Martynova E, Markelova M, Davidyuk Y, Shakirova V, Kaushal N, Baranwal M, Khaertynova IM, Rizvanov A, Foster TL, Khaiboullina S. Garanina E, et al. Front Microbiol. 2022 Apr 18;13:842232. doi: 10.3389/fmicb.2022.842232. eCollection 2022. Front Microbiol. 2022. PMID: 35509311 Free PMC article.
Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63.
Hu Y, Ma C, Wang J. Hu Y, et al. Bio Protoc. 2022 Feb 5;12(3):e4314. doi: 10.21769/BioProtoc.4314. eCollection 2022 Feb 5. Bio Protoc. 2022. PMID: 35284599 Free PMC article.
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
Curreli F, Ahmed S, Victor SMB, Drelich A, Panda SS, Altieri A, Kurkin AV, Tseng CK, Hillyer CD, Debnath AK. Curreli F, et al. Viruses. 2021 Dec 31;14(1):69. doi: 10.3390/v14010069. Viruses. 2021. PMID: 35062273 Free PMC article.

See all "Cited by" articles

References

1. Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827.e19. - PMC - PubMed
1. Public Health England Investigation of novel SARS-CoV-2 variant. 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
1. Eguia RD, Crawford KH, Stevens-Ayers T, et al. A human coronavirus evolves antigenically to escape antibody immunity. bioRxiv. 2020 doi: 10.1101/2020.12.17.423313. published online Dec 18. (preprint) - DOI - PMC - PubMed
1. Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Hepatitis B vaccination. Hum Vaccin Immunother. 2015;11:53–57. - PMC - PubMed
1. Choi B, Choudhary MC, Regan J, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020 doi: 10.1056/NEJMc2031364. published online Nov 11. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal